[1]谢 虹,朱东宁.阿昔洛韦片联合重组人干扰素α-2b喷雾剂在儿童水痘治疗中的作用[J].医学信息,2022,35(17):73-75.[doi:10.3969/j.issn.1006-1959.2022.17.018]
　XIE Hong,ZHU Dong-ning.Effect of Acyclovir Tablets Combined with Recombinant Human Interferon α-2b Spray in the Treatment of Varicella in Children[J].Journal of Medical Information,2022,35(17):73-75.[doi:10.3969/j.issn.1006-1959.2022.17.018]
点击复制

阿昔洛韦片联合重组人干扰素α-2b喷雾剂在儿童水痘治疗中的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年17期
页码:
73-75
栏目:
论著
出版日期:
2022-09-01

文章信息/Info

Title:
Effect of Acyclovir Tablets Combined with Recombinant Human Interferon α-2b Spray in the Treatment of Varicella in Children
文章编号:
1006-1959（2022）17-0073-03
作者:
谢 虹; 朱东宁
（1.青海省妇女儿童医院皮肤科，青海 西宁 810007；2.陕西省妇幼保健院皮肤科，陕西 西安 710004）
Author(s):
XIE Hong; ZHU Dong-ning
(1.Department of Dermatology,Qinghai Provincial Women’s and Children’s Hospital,Xining 810007,Qinghai,China;2.Department of Dermatology,Maternal and Child Health Hospital of Shaanxi Province,Xi’an 710004,Shaanxi,China)
关键词:
重组人干扰素α-2b喷雾剂; 阿昔洛韦片; 水痘
Keywords:
Recombinant human interferon α-2b spray; Aciclovir tablets; Varicella
分类号:
R511.5
DOI:
10.3969/j.issn.1006-1959.2022.17.018
文献标志码:
A
摘要:
目的 研究阿昔洛韦片联合重组人干扰素α-2b喷雾剂在儿童水痘治疗中的作用。方法 选取2020年5月-2021年5月我院诊治的84例水痘儿童为研究对象，采用随机数字表法分为对照组和观察组，各42例。对照组采用阿昔洛韦片治疗，观察组在对照组基础上联合重组人干扰素α-2b喷雾剂治疗，比较两组临床疗效、临床康复指标、临床症状评分、炎性因子指标以及临床不良反应发生率。结果 观察组治疗总有效率为95.24%，高于对照组的83.33%（P＜0.05）；观察组退热时间、水痘停止发作时间、水痘结痂时间、住院时间均短于对照组（P＜0.05）；观察组临床瘙痒、皮疹、疼痛评分低于对照组（P＜0.05）；观察组hs-CRP、WBC水平低于对照组（P＜0.05）；观察组临床不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 阿昔洛韦片联合重组人干扰素α-2b喷雾剂治疗儿童水痘效果良好，可改善患儿临床症状，缩短退热、水痘停止发作、结痂以及住院时间，减轻炎症反应，进一步促进患儿快速康复，且联合治疗不增加不良反应发生几率，安全性较高。
Abstract:
Objective To study the effect of acyclovir tablets combined with recombinant human interferon α-2b spray in the treatment of varicella in children.Methods A total of 84 children with varicella diagnosed and treated in our hospital from May 2020 to May 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 42 cases in each group. The control group was treated with acyclovir tablets, and the observation group was treated with recombinant human interferon α-2b spray on the basis of the control group. The clinical efficacy, clinical rehabilitation index, clinical symptom score, inflammatory factor index and incidence of clinical adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.24%, which was higher than 83.33% in the control group (P<0.05). The antipyretic time, varicella cessation time, varicella scab time and hospitalization time in the observation group were shorter than those in the control group (P<0.05). The scores of clinical pruritus, rash and pain in the observation group were lower than those in the control group (P<0.05). The levels of hs-CRP and WBC in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the incidence of clinical adverse reactions between the observation group and the control group (P>0.05).Conclusion Aciclovir tablets combined with recombinant human interferon α-2b spray is effective in the treatment of varicella in children, which can improve the clinical symptoms of children, shorten the time of fever, varicella cessation, crusting and hospitalization, reduce the inflammatory reaction, and further promote the rapid recovery of children. And the combined treatment does not increase the incidence of adverse reactions, with high safety.

参考文献/References:

[1]胡立红.阿昔洛韦联合地塞米松治疗带状疱疹的疗效[J].河北医药,2017,39(15):2296-2297,2300.[2]陆琪,堵建岗.阿昔洛韦联合泼尼松治疗带状疱疹的临床疗效观察[J].中国基层医药,2017,24(17):2623-2626.[3]陈海平,刘小琴,沈红杰,等.水痘减毒活疫苗流行病学保护效果及安全性研究[J].中华微生物学和免疫学杂志,2016,36(8):600-604.[4]李金玲,谭帅.阿昔洛韦对水痘的治疗价值研究[J].吉林医学,2021,42(8):1901-1902.[5]崔平.银翘解毒汤联合阿昔洛韦治疗儿童水痘临床观察[J].实用中医药杂志,2020,36(9):1162-1163.[6]申昆玲,尚云晓,张贺,等.重组人干扰素α2b喷雾剂(假单胞菌)治疗儿童急性上呼吸道感染有效性和安全性多中心随机对照临床研究[J].中国实用儿科杂志,2019,34(12):1010-1016.[7]杨新利,申艺坤,贾庆岭,等.重组人干扰素α-2b喷雾剂在治疗儿童水痘中作用的研究[J].生物医学工程与临床,2017,21(6):640-642.[8]薛小萍,仵倩红.西咪替丁联合阿昔洛韦治疗小儿水痘的临床分析[J].药物评价研究,2017,40(6):848-850,873.[9]宁零.阿昔洛韦治疗水痘临床疗效评价[J].现代诊断与治疗,2015,26(1):84-85.[10]唐春翊,唐春蕾,郑义宏,等.盐酸伐昔洛韦片联合重组人干扰素α2b凝胶、NUVB治疗成人水痘的疗效观察[J].国际医药卫生导报,2021,27(2):238-240.[11]马卉.重组人干扰素α-1b与伐昔洛韦联合治疗成人水痘疗效观察[J].皮肤病与性病,2018,40(1):72-73.[12]赵瑞玲.干扰素雾化吸入联合阿昔洛韦口服治疗小儿疱疹性咽峡炎临床疗效观察[J].实用医技杂志,2018,25(3):306-307.[13]Beckingham R,Chamberlain S,Bate J.Successful Prevention of Varicella Outbreak With Oral Aciclovir Following Party for Pediatric Oncology Patients[J].J Pediatr Hematol Oncol,2018,40(6):488-489.[14]刘勤.泛昔洛韦治疗带状疱疹临床效果及对患者T细胞亚群、细胞因子和疼痛物质P的影响[J].临床和实验医学杂志,2016,15(21):2126-2129.[15]王凤圈.更昔洛韦与阿昔洛韦治疗小儿病毒性脑炎临床观察[J].中国实用神经疾病杂志,2019,22(5):523-528.[16]岳瑾.喜炎平联合阿昔洛韦治疗小儿水痘112例疗效观察[J].内蒙古医学杂志,2018,50(1):97-98.[17]李艳,杨慧兰.STAT3和Ⅰ型干扰素在水痘-带状疱疹病毒复制过程中作用机制的研究[J].临床皮肤科杂志,2015,44(7):420-422.[18]李艳.西咪替丁联合重组人干扰素治疗儿童流行性腮腺炎的效果[J].河南医学研究,2019,28(15):2759-2760.

更新日期/Last Update: 1900-01-01